Fabrication of dual drug loaded polymeric nanosuspension: Incorporating analytical hierarchy process and data envelopment analysis in the selection of a suitable method

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 2, 2013, Pages 499-504

  Moorthi, C ^a   Kathiresan, K ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Analytical Hierarchy Process; Curcumin; Data Envelopment Analysis; Dual drug loaded polymeric nanosuspension; Nanoprecipitation; Polymeric Nanoparticle

Indexed keywords

CURCUMIN; NANOPARTICLE;

ANALYTIC METHOD; ARTICLE; CANCER THERAPY; DATA ANALYSIS; NANOFABRICATION; PARTICLE SIZE; ZETA POTENTIAL;

EID: 84875930428     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Narain JP, Garg R, Fric A. Non-communicable diseases in the South-East Asia region: burden, strategies and opportunities. Natl Med J India 2011; 24(5): 280-287.
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010; 31(1):100-110.
3. Moorthi C, Manavalan R, Kathiresan. K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 2011; 14(1): 67-77.
4. Brewer E, Coleman J, Lowman A. Emerging technologies of polymeric nanoparticles in cancer drug delivery. J Nanomater 2011; 2011: 1-10.
5. Moorthi C, Kiran K, Manavalan R, Kathiresan K. Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles. Asian Pac J Trop Biomed 2012; 2(11): 841-848.
6. Kinam Park. Nanotechnology: What it can do for drug delivery. J Control Release 2007; 120(1-2): 1-3.
7. Moorthi C, Kathiresan K. Nanotoxicology: Toxicity of engineered nanoparticles and approaches to produce safer nanotherapeutics. International Journal of Pharma Sciences 2012; 2(4): 117-124
8. Nitish K, Peeyush K, Pramod K, Mithilesh K, Rajeev K. Nanotechnology: A focus on treatment of tuberculosis. International Journal of Drug Delivery 2011; 3(1): 25-42.
9. Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005; 172(12):1487-1490.
10. Mohanraj VJ, Chen Y. Nanoparticles-A review. Trop J Pharm Res 2006; 5(1): 561-573.
11. Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine 2011; 19(1): 83-87.
12. Saaty TL. The analytic hierarchy process: Planning, priority setting, resource allocation, McGraw-Hill, New York, 1980.
13. Saaty TL. Relative measurement and its generalization in decision making: Why pair-wise comparisons are central in mathematics for the measurement of intangible factors, the analytic hierarchy/network process. Rev R Acad Cien Serie A Mat 2008; 102(2): 251-318.
14. Yang J, Shi P. Applying analytic hierarchy process in firm's overall performance evaluation: a case study in china. International Journal of Business 2002; 7(1): 29-46.
15. Al-Subhi Al-Harbi KM. Application of the AHP in project management. International Journal of Project Management 2001; 19(1): 19-27.
16. Chauhan KA, Shah NC, Rao RV. The analytic hierarchy process as a decision-support system in the housing sector: A case study. World Applied Sciences Journal 2008; 3(4): 609-613.
17. Kumar S, Parashar N, Haleem A. Analytical hierarchy process applied to vendor selection problem: small scale, medium scale and large scale industries. Business Intelligence Journal 2009; 2(2): 355-362.
18. Mohajeri N, Amin GR. Railway station site selection using analytical hierarchy process and data envelopment analysis. Comput Ind Eng 2010; 59(1): 107-114.
19. Charnes A, Cooper WW, Rhodes E. Measuring the efficiency of decision-making units. Eur J Oper Res 1978; 2(6): 429-444.
20. Banker RD, Charnes A, Cooper WW. Some models for estimating technical and scale inefficiencies in Data Envelopment Analysis. Management Science 1984; 30(9): 1078-1092.
21. Jaiswal J, Gupta SK, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J Control Release 2004; 96(1): 169-178.
22. Hoa LTM, Chi NT, Nguyen LH, Chien DM. Preparation and characterisation of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method. J Exp Nanosci 2012; 7(2): 189-197.
23. Rao JP, Geckeler KE. Polymer nanoparticles: Preparation techniques and size-control parameters. Prog Polym Sci 2011; 36(7): 887-913.
24. Du Toit LC, Pillay V, Choonara YE, Iyuke SE. Formulation and evaluation of a salted-out isoniazid-loaded nanosystem. AAPS Pharmscitech 2007; 9(1): 174-181.
25. Fessi H, Puisieux F, Devissaguet J Ph, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 1989; 55(1): 1-4.
26. Yordanov GG, Dushkin CD. Preparation of poly (butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers. Colloid Polym Sci 2010; 288(9): 1019-1026.
27. Liu M, Zhou Z, Wang X, Xu J, Yang K, Cui Q et al. Formation of poly (L, D-lactide) spheres with controlled size by direct dialysis. Polymer 2007; 48(19): 5767-5779.
28. Choi SW, Kim JH. Design of surface-modified poly (D, L-lactideco-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007; 122(1): 24-30.
29. Schafroth N, Arpagaus C, Jadhav UY, Makne S, Douroumis D. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process. Colloid Surface B 2012; 90: 8-15.
30. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery system. J Control Release 2012; 157(2): 168-182.
31. Gülseren I, Fang Y, Corredig. Zinc incorporation capacity of whey protein nanoparticles prepared with desolvation with ethanol. Food Chemistry 2012; 135(2): 770-774.
32. Gülseren I, Fang Y, Corredig. Whey protein nanoparticles prepared with desolvation with ethanol: Characterization, thermal stability and interfacial behaviour. Food Hydrocolloids 2012; 29(2): 258-264.
33. Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloid Surface B 2012; 90: 21-27.
34. Rajan M, Raj V. Encapsulation, characterisation and in-vitro release of anti-tuberculosis drug using chitosan-poly ethylene glycol nanoparticles. Int J Pharm Pharm Sci 2012; 4(4): 255-259.
35. Varshosaz J, Hassanzadeh F, Mahmoudzadeh M, Sadeghi A. Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology. Powder Technology 2009; 189(1): 97-102.
36. Sekhon BS. Supercritical fluid technology: An overview of pharmaceutical applications. International Journal of PharmTech Research 2010; 2(1): 810-826.
37. Morose G. The 5 principles of design for safer nanotechnology. J Clean Prod 2010; 8(3): 285-289.